AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. Sumitomo Pharma Co., Ltd.
  3. Financials
  4. Net income margin (%)

Sumitomo Pharma Co., Ltd.【JP:4506】

Market cap
¥972.3B
P/E ratio
10.6x
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndNet income margin (%) YoY (%)
Mar 31, 20255.9-105.92%
Mar 31, 2024-100.1+646.55%
Mar 31, 2023-13.4-233.15%
Mar 31, 202210.1-7.55%
Mar 31, 202110.9+29.07%
Mar 31, 20208.4-20.27%
Mar 31, 201910.6-5.32%
Mar 31, 201811.2+58.78%
Mar 31, 20177+14.98%
Mar 31, 20166.1+47.26%
Mar 31, 20154.2+6.02%
Mar 31, 20143.9+20.13%
Mar 31, 20133.3-48.12%
Mar 31, 20126.3

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)